Andolong, Josephine A.

HRN: 28-69-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/15/2026
03/21/2026
IV
500MG
Q8H
OBSTRUCTIVE JAUNDICE PROB SEC TO HEPATOBILIARY PATHOLOGY; R/I HEPATITIS
Remove - Pending Acceptance
03/15/2026
CIPROFLOXACIN 500MG (TAB)
03/15/2026
03/21/2026
PO
500MG
BID
OBSTRUCTIVE JAUNDICE PROB SEC TO HEPATOBILIARY PATHOLOGY; R/I HEPATITIS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: